Skip to main content
Premium Trial:

Request an Annual Quote

Horizon Secures Exclusive License to Cell Lines from UMB

NEW YORK (GenomeWeb News) – Horizon Discovery has licensed exclusive worldwide rights to a panel of human isogenic disease models developed by researchers from the University of Maryland, Baltimore, the firm said today.

The cell lines were developed using Horizon's Genesis platform. They will be added to the firm's X-Man cell models, which the Cambridge, UK-based firm said enables drug discovery researchers to "understand how cancer manifests itself in real patients and helps rationalize many aspects of drug development, and therefore the final cost of new personalized cancer therapies."

Horizon will pay the University of Maryland, Baltimore, up-front fees and royalties on product sales. The term of the license is seven years.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.